論文

国際誌
2022年5月13日

DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production.

Molecular cell
  • Yuki Uchihara
  • Tiara Bunga Mayang Permata
  • Hiro Sato
  • Reika Kawabata-Iwakawa
  • Sayako Katada
  • Wenchao Gu
  • Sangeeta Kakoti
  • Motohiro Yamauchi
  • Reona Kato
  • Soehartati Gondhowiardjo
  • Naoki Hosen
  • Takaaki Yasuhara
  • Atsushi Shibata
  • 全て表示

82
14
開始ページ
2557
終了ページ
2570
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.molcel.2022.04.030

Antigen presentation by the human leukocyte antigen (HLA) on the cell surface is critical for the transduction of the immune signal toward cytotoxic T lymphocytes. DNA damage upregulates HLA class I presentation; however, the mechanism is unclear. Here, we show that DNA-damage-induced HLA (di-HLA) presentation requires an immunoproteasome, PSMB8/9/10, and antigen-transporter, TAP1/2, demonstrating that antigen production is essential. Furthermore, we show that di-HLA presentation requires ATR, AKT, mTORC1, and p70-S6K signaling. Notably, the depletion of CBP20, a factor initiating the pioneer round of translation (PRT) that precedes nonsense-mediated mRNA decay (NMD), abolishes di-HLA presentation, suggesting that di-antigen production requires PRT. RNA-seq analysis demonstrates that DNA damage reduces NMD transcripts in an ATR-dependent manner, consistent with the requirement for ATR in the initiation of PRT/NMD. Finally, bioinformatics analysis identifies that PRT-derived 9-mer peptides bind to HLA and are potentially immunogenic. Therefore, DNA damage signaling produces immunogenic antigens by utilizing the machinery of PRT/NMD.

リンク情報
DOI
https://doi.org/10.1016/j.molcel.2022.04.030
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35594857
ID情報
  • DOI : 10.1016/j.molcel.2022.04.030
  • PubMed ID : 35594857

エクスポート
BibTeX RIS